Objectives: Mechanical complications of median sternotomy may cause significant morbidity and mortality in cardiac surgical patients. This study was aimed at assessing the role of Posthorax support vest (Epple, Inc., Vienna, Austria) in the prevention of sternal complications and the improvement of anatomical healing in patients at high risk for mechanical sternal dehiscence after cardiac surgery by mean of median sternotomy.
INTRODUCTION
Mechanical complications of median sternotomy are less frequent than infective complications, but are a significant cause of morbidity and, occasionally, of mortality in patients undergoing cardiac surgery [1, 2] . These complications can lead to a prolonged hospitalization and sometimes require surgical sternum revision [1, 2] . The increased utilization of resources in terms of the duration of hospitalization, staff work-hours, use of materials and of infrastructure, result in higher health care costs [1, 3] . The limitations imposed on the reimbursement of health care expenditures, especially in recent years, have heightened the importance of preventing post-sternotomy induced complications and the need to reduce re-admissions and mean hospitalization times whilst, at the same time, be able to provide the best patient recovery and subsequent quality of life [4] . Furthermore, anatomically imperfect sternal healing may cause chronic pain and affect the chest mobility for many subsequent years [5] [6] [7] .
The present research has a particular focus on mechanical sternal dehiscence [8] , a topic only marginally treated by other papers [9] [10] [11] .
We have adopted the Posthorax support vest (Epple, Inc., Vienna, Austria) as its design stabilizes the sternum following sternotomy, relieves pressure on the suture wires and reduces pain when breathing, coughing, and during rehabilitation.
The aim of this study was to assess the prevention of mechanical complications of median sternotomy and the improvement of the anatomical sternum healing by means of the utilization of the Posthorax support vest and to evaluate its impact on in-hospital recovery in a group of patients at high risk for sternal dehiscence.
METHODS

Eligibility Requirements and Recruitment
All procedures followed were in accordance with the ethical standards of the responsible national and institutional committee on human experimentation and with the Helsinki Declaration of 1964, as revised in 2013. Informed consent was obtained from all patients for being included in the study. From February 15, 2010 , to September 15, 2014, a prospective, randomized, study was conducted.
The CONSORT flow diagram [12] was adopted in order to assess the number of eligible patients who underwent a cardiac surgical procedure with a median sternotomy (Fig. 1) . We assess for eligibility 2800 consecutive patients. Out of this group, 2490 patients were excluded and 310 patients were included for randomization.
Exclusion criteria were the removal of the chest drains after the 4th post-operative day, the re-admission to the intensive care unit, the need for adoption of mechanical ventilation for any cause and the re-operation for non-mechanically induced complications of sternotomy including mediastinitis, wound, sternal infection, or secondary sternal wound infection and bleeding.
Within the cohort of 310 patients, 155 patients were allocated in group A (GA), in Fig. 1 The CONSORT diagram showing the flow of participants through each stage of a randomized study whom the Posthorax support vest was used following the removal of the chest drains for their entire hospitalization and until 90 days after discharge, whereas the remaining 155 patients were allocated in group B (GB), in whom no support vests were used after surgery.
A power analysis was performed to determine the adequate sample size. Based on preliminary study results [9, 10] diagnosed by a respiratory specialist [9] [10] [11] 13] . Randomization of patients and assignment to each study group was performed immediately after the chest drains removal via a random number generator program. The study variables recorded for both groups were: the need for re-operation for mechanically induced sternum complications, the number of requests for analgesic supplementation, the quality of life as measured by the EQ-5D format [14] , which was administered to patients at the moment of discharge, the duration of hospitalization (in days), the number of patients that were re-admitted only for post-sternotomy mechanically induced complications at any time from the start of the study until the end of follow-up and their length of stay following re-admission (in days).
Being that this an monocentric study, no trial registry was created to perform our analysis; data were deposited in/or recovered from patients' medical records.
Sternum Closure
Routine sternum closure as per institutional practice was followed in all patients. Seven stainless-steel sternum wire sutures were passed though the sternum at approximately Any activity precaution after sternotomy was given to patients in according with well-established clinical and therapeutical practices.
Analgesia Protocols
All patients in both groups received a similar analgesic protocol, which included 4 mg of morphine sulphate IV and 500 mg of paracetamol IV every 8 h with 4 mg of ondansetron IV every 12 h during the first 48 h post-operatively. Subsequently, the patients received 500 mg paracetamol IV every 8 h only. The additional on-demand analgesic supplementation to the standard analgesic protocol was 500 mg of paracetamol IV up to a maximum total of 2500 mg/day and afterwards 30 mg of ketorolac IV every 12 h. Pain levels
were assessed every time a patient requested supplemental analgesia by using the visual analogue scale (VAS) to obtain a score [16] .
Anatomical Recovery Evaluation
All patients underwent a routine anterior-posterior chest radiograph at discharge in order to assess anatomical sternum recovery by evaluating the sternotomy line. Findings such as a mid-sternum line of lucency [2 mm indicating sternum diastasis [17] , any sternum wire displacement, or any obvious interruption/ dislocation were recorded. Given that the maximum dehiscence risk occurs during the first post-operative week, a single chest radiogram at discharge was deemed adequate to assess sternum diastasis and in addition to inspection of the thorax to evaluate the sternum instability and/or pain at coughing.
The physician involved in evaluating the chest X-rays was blinded according to treatment group.
During the 90-day follow-up period after discharge, patients were monitored at their visits to the outpatient clinic or by telephone interviews focusing on sternal wound problems after discharge. 4.7 ± 0.6, p = 0.002), and those which underwent BIMA harvesting (1.8 ± 0.1 vs.
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4.6 ± 0.7, p\0.001) ( Table 3 (Table 4) . At discharge there were no cases of re-operation for mechanically induced sternum complication in group A vs. seven cases in group B (Table 5) . At discharge, a sternotomy stripe of lucency [2 mm was observed in seven patients in group A and in 31 patients in group B (4.5 vs. 20%, p = 0.005), and a clear For the legend, see Table 1 interruption/dislocation of the sternotomy line was observed in eight patients in group B and none in group A (5.2 vs. 0%) ( Table 5 ). The average days of in-hospital stay were significantly lower in group A compared to group B (7 ± 2.7 vs. 12 ± 3.4, p = 0.02) ( Table 5) .
None of the patients in group A vs. three patients of group B developed post-operative pneumonia. In group B, 16 patients were re-admitted during the follow-up period for post-sternotomy mechanically induced complications vs. six patients in group A (3.9 vs. 10.3%, p = 0.05) ( Table 5 ). The mean post re-admission hospital stay was significantly lower in group A (8 ± 3.2 days) vs. group B (24 ± 7 days, p = 0.05) ( Table 5 ). There were no other complications of any kind reported with the usage of the Posthorax sternum support vest in group A patients. The mean follow-up was 2.4 ± 2.1 years (range, 0.83-5.25 years).
Freedom from mechanical events at 5 years was 95.8 ± 6.1 in GA and 84.7 ± 5.3 in GB (p\0.001).
DISCUSSION
The Posthorax vest is the latest technological generation of sternum support corsets [18] . It has been designed to stabilize the sternum following sternotomy so as to avoid excessive stress on the sternum wires during bone healing [17] . It differs from other previous vest designs because its structure is open in the front and is not based on a circumferential elastic band design making it less restrictive [18] . This open structure is also more hygienic, as it avoids compression and contamination of the skin wound. The non-elastic band structure avoids harmful continuous compression on the thorax and interference with respiratory effort and only provides support during excessive chest stress such as when coughing, mobilizing, or performing rehabilitation exercises [18] . In other words, the patient's chest is free to move during breathing and is only supported during excessive or non-physiological movement, thus reducing the potential risk of respiratory complications. None of the patients who utilized the Posthorax support vest in our series developed post-operative pneumonia or any other kind of complications associated with its use. Our findings concerning the incidence of respiratory complications with Posthorax support vest adoption is not statistically 
Study Limitations
The study presents a number of limitations:
firstly, we used EQ-5D format only as a descriptive tool because the time of observation of the study has been limited only to the hospital stay in order to eliminate bias related with differences in managing or behavior of patients after discharge from the hospital. To overcome this problem, we assumed the EQ-5D of the control group as the baseline. Furthermore, the use of baseline data inside the groups is not proper if we consider the fast changes of health status during the early postoperative period, a factor that makes EQ 5 as not reliable. Another limitation might be the antalgic protocol of the study. Our institution has not arbitrarily implemented this protocol, but it followed the directives of the ''Hospital without pain'' project that has been established by the Italian National Health Service (NHS) within all specialties for all hospitals. A further potential limitation is the 
